3037:TWSEUnimicron Technology Corp. Analysis
Data as of 2026-08-23 - not real-time
NT$1,085.00
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At TWD 1,085.00, Unimicron Technology Corp. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. Over a rolling month the price has gained 24.0%. Relative strength is 61.0 — approaching overbought — and the MACD signal is bullish. Price has been bracketed by support at TWD 653.00 and resistance at TWD 1,200.00.
Multiples put this in overvalued territory: 71.4 times earnings against the sector's 35.2. Analyst price targets sit 15.9% above the current price. Revenue is growing at 32.1% on a 16.0% profit margin. The 0.18% dividend yield looks covered by current payout levels.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 96.8%, a beta of 1.77 and a maximum drawdown of 36.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 2/10 conviction on the long call.
Multiples put this in overvalued territory: 71.4 times earnings against the sector's 35.2. Analyst price targets sit 15.9% above the current price. Revenue is growing at 32.1% on a 16.0% profit margin. The 0.18% dividend yield looks covered by current payout levels.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 96.8%, a beta of 1.77 and a maximum drawdown of 36.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Near-term and long-term part ways here — buy short-term against hold longer out, with 2/10 conviction on the long call.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 587.23
- MACD momentum is positive
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 71.4 versus sector average of 35.2
- Trading above the 200-day average of 587.23
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 71.4 versus sector average of 35.2
- Analyst targets imply +15.9% versus the current price
- Profit margin of 16.0% is healthy
Key Metrics & Analysis
Financial Health
Revenue Growth32.10%
Profit Margin16.03%
P/E Ratio71.4
ROE22.65%
ROA3.05%
Debt/Equity39.30
P/B Ratio13.9
Op. Cash FlowNT$19.6B
Free Cash FlowNT$662.5M
Industry P/E35.2
Technical Analysis
TrendBullish
RSI61.0
SupportNT$653.00
ResistanceNT$1,200.00
MA 20NT$955.65
MA 50NT$936.54
MA 200NT$587.23
MACDBullish
VolumeDecreasing
Fear & Greed Index94.41
Valuation
Fair ValueNT$41.48
Target PriceNT$1,257.89
Upside/Downside15.94%
GradeOvervalued
TypeGrowth
Dividend Yield0.18%
Risk Assessment
Beta1.77
Volatility96.80%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.